Italia markets closed

Coloplast A/S (CLPBF)

Other OTC - Other OTC Prezzo differito. Valuta in USD.
Aggiungi a watchlist
131,30-0,71 (-0,54%)
Alla chiusura: 10:03AM EDT

Coloplast A/S

Holtedam 1-3
Humlebæk 3050
Denmark
45 49 11 11 11
https://www.coloplast.com

Settore/iHealthcare
SettoreMedical Instruments & Supplies
Impiegati a tempo pieno15.751

Figure dirigenziali chiave

NomeTitoloRetribuzioneEsercitateAnno di nascita
Mr. Kristian VillumsenPresident & CEO2,54MN/D1970
Mr. Anders Lonning-SkovgaardExecutive VP & CFO1,3MN/D1972
Mr. Allan RasmussenExecutive Vice President of Global Operations1,15MN/D1967
Mr. Nicolai Buhl AndersenExecutive Vice President of Innovation1,1MN/D1969
Mr. Paul MarcunExecutive Vice President of Growth1,32MN/D1967
Mr. Thomas BarfodSenior Controller & Employees Representative Director65,24kN/D1970
Ellen BjurgertVice President of Investor RelationsN/DN/DN/D
Dennis KaysenDirector of Corporate CommunicationsN/DN/DN/D
Dorthe RonnauSenior Vice President of People & CultureN/DN/D1966
Mr. Alain MorvanSenior Vice President of Sales EuropeN/DN/DN/D
Gli importi risalgono al giorno 31 dicembre 2023 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in USD.

Descrizione

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. The company was founded in 1954 and is headquartered in Humlebæk, Denmark.

Governance aziendale

L'ISS Governance QualityScore di Coloplast A/S al 1 marzo 2024 è 3. I criteri di valutazione fondamentali sono revisione: 1; Consiglio di Amministrazione: 4; diritti degli azionisti: 9; retribuzione: 2.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.